Previous 10 | Next 10 |
Image source: The Motley Fool. Athenex, Inc. (NASDAQ: ATNX) Q1 2021 Earnings Call May 7, 2021 , 8:00 p.m. ET Operator Continue reading For further details see: Athenex, Inc. (ATNX) Q1 2021 Earnings Call Transcript
ChemoCentryx (CCXI) -49% after FDA panel split 9-9 on efficacy for Chemocentryx's vasculitis candidate avacopan and reports outcome of FDA’s expert panel meeting on avacopan.Orphazyme (ORPH) -28% after arimoclomol flunks late-stage amyotrophic lateral sclerosi...
Athenex (ATNX): Q1 GAAP EPS of -$0.27 beats by $0.13.Revenue of $41.03M (-12.6% Y/Y) beats by $16.49M.As of March 31, 2021, the Company had cash and cash equivalents of $48.0 million, restricted cash of $16.5 million, and short-term investments of $123.2 million.In terms of product sales guid...
Plan to Request Type A Meeting with the FDA for Oral Paclitaxel by the End of May Klisyri® Launched in the U.S. in February 2021 Acquired Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform in May 2021 Management to Host Con...
Shares of Athenex (NASDAQ: ATNX) soared on Wednesday after the pharmaceutical company announced a game-changing merger. By the close of trading, Athenex's stock price was up 22.6% after rising as much as 55% earlier in the day. Athenex reached a deal to buy Kuur Therapeutics...
Gainers: Regional Health Properties (RHE) +124%.SunLink Health Systems (SSY) +66%.Nemaura Medical (NMRD) +60%.Chiasma (CHMA) +48%.Athenex (ATNX) +31%.Caesarstone (CSTE) +30%.Hayward (HAYW) +28%.Altisource Portfolio Solutions (ASPS) +26%.Big 5 Sporting Goods (BGFV) +26%.American...
Gainers: Regional Health Properties (RHE) +71%, Chiasma CHMA +45%, Nemaura Medical (NMRD) +35%, Athenex (ATNX) +40%, iBio (IBIO) +29%.Losers: Cocrystal Pharma COCP -32%, Esperion Therapeutics ESPR -26%, Adamis Pharmaceuticals (ADMP) ...
Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the halfway point of the week, investors! Here at InvestorPlace , we’re starting the day off like we always do with a look at the biggest pre-market stock movers. Join us as we list out t...
Clinical stage biopharmaceutical company Athenex (ATNX) has acquired immunotherapy developer Kuur Therapeutics in a deal valued at $185M, in a bid to bolster its cell therapy portfolio.The deal includes an upfront payment of $70M and potential milestone payments of up to $...
News, Short Squeeze, Breakout and More Instantly...
Athenex Inc. Company Name:
ATNX Stock Symbol:
NASDAQ Market:
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX) (...
Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO PR Newswire SAN FRANCISCO , May 1, 2023 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (Quantum Leap) and At...
Exploring a range of strategic alternatives Revenues from product sales from continued operations increased +27% Y/Y in 4Q 2022 and +33% for full year 2022 Net Loss attributable to Athenex was $34.2 million, or $4.28 per diluted share in 4Q2022, compared to $104.4 million, or $1...